RXRX News & Events

Recursion Pharmaceuticals (RXRX) announced that Vicki Goodman will become Recursion's chief medical officer effective April 6 as David Mauro transitions out of the role. Previously, she was executive VP, product development and medical affairs and chief medical officer at Exelixis (EXEL).

Latest data shows the largest indicative borrow rate increases among liquid option names include: Klarna Group PLC (KLAR) 31.14% +0.99, MSOX ETF (MSOX) 17.62% +0.72, Beyond Meat (BYND) 31.30% +0.59, PROSHARES ULTRA BITCOIN ETF (BITU) 3.88% +0.40, Plains GP Holdings (PAGP) 1.12% +0.37, Rezolve AI Ltd (RZLV) 2.46% +0.34, Aurora Cannabis (ACB) 11.33% +0.34, Kodiak AI, Inc. Common Stock (KDK) 43.37% +0.32, T-REX 2X LONG NVIDIA DAILY (NVDX) 12.47% +0.23, and Recursion Pharmaceuticals (RXRX) 1.31% +0.23.

PacBio (PACB) announced the appointment of Christopher Gibson, Ph.D., to PacBio's Board of Directors. Dr. Gibson is the co-founder and Chairman of the Board of Directors of Recursion (RXRX).